L-Citrulline Dose Finding Safety Study in MELAS

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 22, 2021

Primary Completion Date

April 30, 2024

Study Completion Date

June 1, 2024

Conditions
MELAS Syndrome
Interventions
DRUG

L-Citrulline

To determine the safest maximum dose of L-Citrulline which could be used as a potential treatment for adults with disorder of energy metabolism called MELAS

Trial Locations (1)

77030

Baylor St. Luke'S Medical Center, Houston

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

collaborator

University of South Florida

OTHER

collaborator

Columbia University

OTHER

lead

Baylor College of Medicine

OTHER